Lawrence Steinman
Director at Pasithea Therapeutics Corp. (KTTA)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return-29.8%
vs. S&P 500-31.0%
Beat the market0%
Paper profit on buys−$38K
Total bought / sold$100K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Dec 1SEC | KTTAPasithea Therapeutics Corp. | Buy | 133,333199,691 held (+201%) | $0.75 | $100K | -37.6% |
- Buy
Director Lawrence Steinman bought $100K of KTTA at $0.75 — first open-market purchase in our records; raises the stake by 201%.